Quarterly loss, page-17

First 17 Last

Share
Profile

Follow
Keffola

1,558 Posts.

28

25/10/19

16:37

Post #: 41071447
Share

Originally posted by Blommer: ↑

the holder of the 10mil shares who was selling should hold off if the sp gets too low.

I'm expecting CFN of at least $1mil average for next two 4Cs, going by:

-their stated expected manufacturing expenditure in the last two 4Cs of ~ $1.0mil and $1.7mil, respectively
-i'm using their last two 4Cs because their asset turnover multiples aren't particularly fast at around ~1.7x meaning they only cycle through their working capital around 1.7 times per year. I'm actually allowing for them to speed up a little bit here to 2x.
-their stated current expected cash outflows of $3.2 mil from the last 4C
-their most recent gross margin was 30% from annual report
-this gives me expected revenues of around $1.4 mil and $2.4 mil for the next two Qs
-and a net cash outflow of $1.8mil and $0.8mil for the next two Qs

if they are going to become profitable ever, they will need to spend significantly more in the FY20Q2 and subsequent periods coming on manufacturing, but they can't generate their own funds still and cash reserves are going to be as good as dried up by end of year according to the basic analysis, maybe a mil or so left, unless they go to market for CR.

The $45 mil potential product pipeline is really shown here to be the pipedream most should recognise it to be. Where are they going to get the cash for the working capital to pay for these production costs? They barely have the capital available to generate even $4million in sales for the next half.

Even if they do get all the cash they need, whoever provides it will be the new owners.

Expand

Will find out in a few days with the 4C.

Think they'll do significantly better than a net cash outflow of $1.8mil.

AJX Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ITM

Fast-track assaying yields 182 g/t gold for iTech at new NT play

AWJ

Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance

RZI

Raiz to exit Malaysia; focus on Australian business growth

STN

Saturn’s stars have aligned for the gold explorer’s Apollo Project

CUV

British study shows Clinuvel drug effective on DNA of UV-damaged skin

There are more pages in this discussion • 22 more messages in this thread...

First 17 Last

Add AJX (ASX) to my watchlist

(20min delay)
Last 1.2¢		Change 0.000(0.00%)		Mkt cap ! $18.74M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
3	462637	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	420051	3

View Market Depth

No.	Vol.	Price($)
3	462637	0.011
4	4132035	0.010
3	511210	0.009
2	182600	0.008
1	200000	0.007

Price($)	Vol.	No.
0.012	420051	3
0.013	1758914	3
0.014	363311	2
0.015	36316	2
0.017	106500	2

Last trade - 10.16am 05/07/2024 (20 minute delay)

AJX (ASX) Chart

Day chart unavailable

Quarterly loss, page-17

Fast-track assaying yields 182 g/t gold for iTech at new NT play

Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance

Raiz to exit Malaysia; focus on Australian business growth

Saturn’s stars have aligned for the gold explorer’s Apollo Project

British study shows Clinuvel drug effective on DNA of UV-damaged skin

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Quarterly loss, page-17

Top Stories

Fast-track assaying yields 182 g/t gold for iTech at new NT play

Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance

Raiz to exit Malaysia; focus on Australian business growth

Saturn’s stars have aligned for the gold explorer’s Apollo Project

British study shows Clinuvel drug effective on DNA of UV-damaged skin

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News